The Effect of A New Mixture of Sugar and Sugar-Alcohol (Lacritose) on Blood Glucose and Lipids and the Possible Adverse Reactions in Patients with Type 2 Diabetes: A Triple-Blind Randomized Clinical Trial

Background: A new sweetener with the commercial name of Lacritose has been recently produced, which is a combination of four simple sugars (lactose, fructose, sucrose, erythritol), with specific ingredients and percentages. This study aimed to assess glycemic response and short term gastrointestinal...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Masoud Rahmanian, Zohre Mozafari, Danial Chaleshi, Marzieh Shukohifar, Saeedeh Jam-Ashkezari
Formato: article
Lenguaje:EN
Publicado: Shahid Sadoughi University of Medical Sciences and Health Services 2021
Materias:
S
Acceso en línea:https://doaj.org/article/797299719603416780ef7e5d562f5bf2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:797299719603416780ef7e5d562f5bf2
record_format dspace
spelling oai:doaj.org-article:797299719603416780ef7e5d562f5bf22021-11-03T17:02:28ZThe Effect of A New Mixture of Sugar and Sugar-Alcohol (Lacritose) on Blood Glucose and Lipids and the Possible Adverse Reactions in Patients with Type 2 Diabetes: A Triple-Blind Randomized Clinical Trial2476-74172476-7425https://doaj.org/article/797299719603416780ef7e5d562f5bf22021-11-01T00:00:00Zhttp://jnfs.ssu.ac.ir/article-1-365-en.htmlhttps://doaj.org/toc/2476-7417https://doaj.org/toc/2476-7425Background: A new sweetener with the commercial name of Lacritose has been recently produced, which is a combination of four simple sugars (lactose, fructose, sucrose, erythritol), with specific ingredients and percentages. This study aimed to assess glycemic response and short term gastrointestinal reactions in type 2 diabetic patients. Methods: In this triple-blind randomized clinical trial, 30 diabetic patients referred to Yazd Diabetes Research Center in 2018 were included. After collecting the primary data, they were assigned into three groups, including sucrose consumers as the control group, sucrose-lactose, and lacritose as the groups of consumers group. They were followed for two weeks, and fasting blood glucose (FBG), 2-hour postprandial test (2HPP), fructose amine, SGOT, SGPT, urea, creatinine, and insulin resistance index (HOMA-IR) were assessed. Results: In lacritose consumers, significant reductions were seen in FBG and 2HPP (P < 0.001 and P = 0.05, respectively), although changes among the groups were not significant. In sucrose-lacritose consumers, FBG and cholesterol levels decreased (P = 0.04 and P = 0.03, respectively). In sucrose consumers, no reduction was seen. HOMA-IR did not significantly decrease, but intergroup changes were obvious. Conclusion: The lacritose effects on FBG and 2HPP were significantly evident, but the other metabolic indices did not show any significant change.Masoud RahmanianZohre MozafariDanial ChaleshiMarzieh ShukohifarSaeedeh Jam-AshkezariShahid Sadoughi University of Medical Sciences and Health Servicesarticlediabeteslactosesugarssweetenersblood glucose controlAgricultureSNutrition. Foods and food supplyTX341-641ENJournal of Nutrition and Food Security, Vol 6, Iss 4, Pp 360-366 (2021)
institution DOAJ
collection DOAJ
language EN
topic diabetes
lactose
sugars
sweeteners
blood glucose control
Agriculture
S
Nutrition. Foods and food supply
TX341-641
spellingShingle diabetes
lactose
sugars
sweeteners
blood glucose control
Agriculture
S
Nutrition. Foods and food supply
TX341-641
Masoud Rahmanian
Zohre Mozafari
Danial Chaleshi
Marzieh Shukohifar
Saeedeh Jam-Ashkezari
The Effect of A New Mixture of Sugar and Sugar-Alcohol (Lacritose) on Blood Glucose and Lipids and the Possible Adverse Reactions in Patients with Type 2 Diabetes: A Triple-Blind Randomized Clinical Trial
description Background: A new sweetener with the commercial name of Lacritose has been recently produced, which is a combination of four simple sugars (lactose, fructose, sucrose, erythritol), with specific ingredients and percentages. This study aimed to assess glycemic response and short term gastrointestinal reactions in type 2 diabetic patients. Methods: In this triple-blind randomized clinical trial, 30 diabetic patients referred to Yazd Diabetes Research Center in 2018 were included. After collecting the primary data, they were assigned into three groups, including sucrose consumers as the control group, sucrose-lactose, and lacritose as the groups of consumers group. They were followed for two weeks, and fasting blood glucose (FBG), 2-hour postprandial test (2HPP), fructose amine, SGOT, SGPT, urea, creatinine, and insulin resistance index (HOMA-IR) were assessed. Results: In lacritose consumers, significant reductions were seen in FBG and 2HPP (P < 0.001 and P = 0.05, respectively), although changes among the groups were not significant. In sucrose-lacritose consumers, FBG and cholesterol levels decreased (P = 0.04 and P = 0.03, respectively). In sucrose consumers, no reduction was seen. HOMA-IR did not significantly decrease, but intergroup changes were obvious. Conclusion: The lacritose effects on FBG and 2HPP were significantly evident, but the other metabolic indices did not show any significant change.
format article
author Masoud Rahmanian
Zohre Mozafari
Danial Chaleshi
Marzieh Shukohifar
Saeedeh Jam-Ashkezari
author_facet Masoud Rahmanian
Zohre Mozafari
Danial Chaleshi
Marzieh Shukohifar
Saeedeh Jam-Ashkezari
author_sort Masoud Rahmanian
title The Effect of A New Mixture of Sugar and Sugar-Alcohol (Lacritose) on Blood Glucose and Lipids and the Possible Adverse Reactions in Patients with Type 2 Diabetes: A Triple-Blind Randomized Clinical Trial
title_short The Effect of A New Mixture of Sugar and Sugar-Alcohol (Lacritose) on Blood Glucose and Lipids and the Possible Adverse Reactions in Patients with Type 2 Diabetes: A Triple-Blind Randomized Clinical Trial
title_full The Effect of A New Mixture of Sugar and Sugar-Alcohol (Lacritose) on Blood Glucose and Lipids and the Possible Adverse Reactions in Patients with Type 2 Diabetes: A Triple-Blind Randomized Clinical Trial
title_fullStr The Effect of A New Mixture of Sugar and Sugar-Alcohol (Lacritose) on Blood Glucose and Lipids and the Possible Adverse Reactions in Patients with Type 2 Diabetes: A Triple-Blind Randomized Clinical Trial
title_full_unstemmed The Effect of A New Mixture of Sugar and Sugar-Alcohol (Lacritose) on Blood Glucose and Lipids and the Possible Adverse Reactions in Patients with Type 2 Diabetes: A Triple-Blind Randomized Clinical Trial
title_sort effect of a new mixture of sugar and sugar-alcohol (lacritose) on blood glucose and lipids and the possible adverse reactions in patients with type 2 diabetes: a triple-blind randomized clinical trial
publisher Shahid Sadoughi University of Medical Sciences and Health Services
publishDate 2021
url https://doaj.org/article/797299719603416780ef7e5d562f5bf2
work_keys_str_mv AT masoudrahmanian theeffectofanewmixtureofsugarandsugaralcohollacritoseonbloodglucoseandlipidsandthepossibleadversereactionsinpatientswithtype2diabetesatripleblindrandomizedclinicaltrial
AT zohremozafari theeffectofanewmixtureofsugarandsugaralcohollacritoseonbloodglucoseandlipidsandthepossibleadversereactionsinpatientswithtype2diabetesatripleblindrandomizedclinicaltrial
AT danialchaleshi theeffectofanewmixtureofsugarandsugaralcohollacritoseonbloodglucoseandlipidsandthepossibleadversereactionsinpatientswithtype2diabetesatripleblindrandomizedclinicaltrial
AT marziehshukohifar theeffectofanewmixtureofsugarandsugaralcohollacritoseonbloodglucoseandlipidsandthepossibleadversereactionsinpatientswithtype2diabetesatripleblindrandomizedclinicaltrial
AT saeedehjamashkezari theeffectofanewmixtureofsugarandsugaralcohollacritoseonbloodglucoseandlipidsandthepossibleadversereactionsinpatientswithtype2diabetesatripleblindrandomizedclinicaltrial
AT masoudrahmanian effectofanewmixtureofsugarandsugaralcohollacritoseonbloodglucoseandlipidsandthepossibleadversereactionsinpatientswithtype2diabetesatripleblindrandomizedclinicaltrial
AT zohremozafari effectofanewmixtureofsugarandsugaralcohollacritoseonbloodglucoseandlipidsandthepossibleadversereactionsinpatientswithtype2diabetesatripleblindrandomizedclinicaltrial
AT danialchaleshi effectofanewmixtureofsugarandsugaralcohollacritoseonbloodglucoseandlipidsandthepossibleadversereactionsinpatientswithtype2diabetesatripleblindrandomizedclinicaltrial
AT marziehshukohifar effectofanewmixtureofsugarandsugaralcohollacritoseonbloodglucoseandlipidsandthepossibleadversereactionsinpatientswithtype2diabetesatripleblindrandomizedclinicaltrial
AT saeedehjamashkezari effectofanewmixtureofsugarandsugaralcohollacritoseonbloodglucoseandlipidsandthepossibleadversereactionsinpatientswithtype2diabetesatripleblindrandomizedclinicaltrial
_version_ 1718445521708777472